chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reportedly had Tdap vaccination to the left deltoid area and Varicella vaccination to the right triceps area with development of right arm edema, redness, and pain that banded across his chest starting on May 22nd (the day after vaccination). He was admitted to Medical Center for central, sharp chest pain and ST-segment elevation on EKG. He underwent cardiac catheterization to rule out STEMI and was diagnosed with pericarditis without critical coronary artery stenosis. He was found to have a lateral myocardial wall abnormality and small pericardial effusion. Blood cultures are still pending to rule out bacteremia. Pt reports discovery post-vaccination of prior varicella infection as a child.
child reports pain at injection site for multiple days after injection in left arm; the pain persists without movement or touching site; mother phones public health office today 5/17/19 to report this adverse event; at this time she reports child states that her arm still hurts but usually only when touching injection site now, and not without movement; no redness (other than scab from injection) or swelling per mothers phone call report
Pt started experiencing symptoms of stroke and went to hospital. Dx was Bell's palsy. Received prescriptions for acyclovir and prednisone and was discharged same day.
(R) thigh (lateral) sub-cut VARIVAX site became red and indurated 10 days post vaccine no fever on pain and seen office 11 day post vaccine 2 x  cm induration.
Sick; something doesn't feel right/doesn't feel good; so nauseated, major nausea for 3-4 days; This spontaneous case was reported by a nurse and describes the occurrence of ILLNESS (Sick), FEELING ABNORMAL (something doesn't feel right/doesn't feel good) and NAUSEA (so nauseated, major nausea for 3-4 days) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A, 032F21A and 024M20A) for COVID-19 vaccination.     The patient's past medical history included Miscarriage.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced ILLNESS (Sick), FEELING ABNORMAL (something doesn't feel right/doesn't feel good) and NAUSEA (so nauseated, major nausea for 3-4 days). At the time of the report, ILLNESS (Sick), FEELING ABNORMAL (something doesn't feel right/doesn't feel good) and NAUSEA (so nauseated, major nausea for 3-4 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter.  No treatment was provided by the reporter.  It was reported that it was almost the same as the second dose, might be worse. She stated that she was not pregnant or breastfeeding. She wanted to know if that a side effect of generally not feeling good and nausea. She stated it's just odd.   This case was linked to MOD-2021-390064 (Patient Link).
Concerned that she didn't get enough of the vaccine; Headache; Felt dizzy; Sore arm; Bruise at injection site; Started not feeling good; Injection site swelled like "a piece of bubble gum"; Bled excessively; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE HAEMORRHAGE (Bled excessively), DIZZINESS (Felt dizzy), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE BRUISING (Bruise at injection site) and FEELING ABNORMAL (Started not feeling good) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol (PMH includes controlled cholesterol), Sulfonamide allergy (Sulfa drugs allergy.) and Drug allergy (Feldene allergy.).   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Bled excessively) and VACCINATION SITE SWELLING (Injection site swelled like "a piece of bubble gum"). On 21-Apr-2021, the patient experienced DIZZINESS (Felt dizzy), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE BRUISING (Bruise at injection site) and HEADACHE (Headache). 21-Apr-2021, the patient experienced FEELING ABNORMAL (Started not feeling good). On 26-Apr-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Concerned that she didn't get enough of the vaccine). The patient was treated with Manual therapy (Band aid) for Vaccination site haemorrhage and Manual therapy (massage and pressure applied) for Vaccination site swelling. On 26-Apr-2021, VACCINATION SITE BRUISING (Bruise at injection site) and INCORRECT DOSE ADMINISTERED (Concerned that she didn't get enough of the vaccine) had resolved. At the time of the report, VACCINATION SITE HAEMORRHAGE (Bled excessively), DIZZINESS (Felt dizzy), PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (Started not feeling good), HEADACHE (Headache) and VACCINATION SITE SWELLING (Injection site swelled like "a piece of bubble gum") had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provider by the reporter.  Action taken with mRNA-1273 in response to the events was not Applicable.
Per pt "during the evening chills came on and while in bed I was cold, hands and feet, and I was shaking/vibrating, extremely rapid. I got up and put on woolen socks. In the morning (10/03/13) when I was getting out of bed, I realized I was dizzy, no sense of balance and wobbly and thought I was going to fall down, but I didn't. I could not focus my eyes, had sore back muscles (pain) and felt exhausted most of the day. I took blood pressure readings 4 times throughout the day and had irregular heart beat on all 4 occasions. Around 3pm, some symptoms (dizziness, wobbly, etc) were subsiding. On 10/04/13, the above symptoms were gone and I was able to mow my lawn".
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Additional Details: Patient fainted minutes after receiving the dose. He was sweating and disorientated after passing out. Recovered with iced tea and some crackers. Took about 30 minutes before he was comfortable standing again. He has never previously reacted to a vaccine before
Feeling kind of weird my arm; Barely can use my arm, my arm is like it''s popping; I could barely use this arm; Can''t even use my arm; her arm is "popping", cramping and aching; sometimes she feels a sudden pain in the arm similar to a "shock"; she cannot work properly because of the side effects; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Aug2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious), outcome "unknown", described as "Feeling kind of weird my arm"; JOINT RANGE OF MOTION DECREASED (non-serious), outcome "unknown", described as "Barely can use my arm, my arm is like it''s popping; I could barely use this arm; Can''t even use my arm"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "her arm is "popping", cramping and aching"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sometimes she feels a sudden pain in the arm similar to a "shock""; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious), outcome "unknown", described as "she cannot work properly because of the side effects".  Additional information:  she mentioned that her arm is "popping", cramping and aching, sometimes she feels a sudden pain in the arm similar to a "shock". She stated that she did not have any health problems. She mentioned that she cannot work properly.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Woke up with facial numbness and droop, speech slurred, Facial ache like a bruise.  Face appears swollen at times, but resolves and comes back. 11/24/2009 MD records for 11/13/2009,  Dx Bell's palsy patient with c/o's numb lips, can't close lt eye, rx'd prednisone
Client of a group home requested to be vaccinated with the Johnson and Johnson (J&J) vaccine. Client was asked if he had ever had an adverse reaction to the Covid-19 vaccine, Client stated no. The J&J vaccine was administered in the client's right deltoid. Client went into observation area. When the Health Worker was entering the administration of the J&J into system, it was noted the client had previously received 1 dose of the Moderna vaccine on 03/24/2021. Client remained in the observation area for 30 minutes without incident. Client reported no adverse symptoms. Client was instructed not to get any more Covid-19 vaccines. Administrator was notified of the event.
headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and NAUSEA (nausea) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache) and NAUSEA (nausea). At the time of the report, HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
On 4/16/2021 at 2:17 PM, 17-Year-old white male received his first dose of Pfizer vaccine lot #ER8729 0.3 ml to his right deltoid. At 2:28 pm while patient in the observation area, patient noted pale in color, he was complaining of dizziness, blurred vision. Patient taken to designated area while provided complete privacy. Vital signs as followed: BP 90/60, respiration 16, pulse 54, o2 sat 97% on room air, patient lowered to the floor with his feet elevated . 2: 33 pm Patient voiced that his feeling better. Patient skin color improved 100/80, respiration 18, o2 sat 98% on room air. Patient endorsed allergy to penicillin which he describes reaction as hives, also as per patient and his mother who currently in vaccine clinic, patient had similar above reaction to flu vaccine a year ago. Patient denies any known past medical history nor currently on medication.  2:38pm Sitting vital sign : BP 110/70, pulse 76, o2 sat 97%, resp 18, Patient denies any further symptoms.  2:43 Pm Standing BP 120/80, pulse 65, o2 sat 97%, resp 18. Patient remained stable, able to ambulate steady gait. No complain voice Patient released thirty minutes post observation accompanied by his mother in stable condition. Writer recommended to patient if symptoms reoccur to sick immediate medical help. Patient and family verbalized understanding.
Immediately left arm got sore, couldn't move arm all day into the next day. Had dizziness, headache for 24 hours, neck pain, and vomited once. Still has soreness, aches all over and feeling tired.
MATERNAL EXPOSURE DURING PREGNANCY; This solicited pregnancy report received from a patient concerned a 44 year old female. The patient was enrolled in a non-company sponsored study: COVID 19 Registryt number: C00031). The patient's weight was 47.62 kilograms, and height was not reported. The patient's past medical history included multigravida, and concurrent conditions included anxiety, and low blood pressure. The patient initiated treatment with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. Concomitant medications included ascorbic acid/biotin/minerals nos/nicotinic acid/retinol/tocopherol/vitamin b nos/vitamin d nos, cetirizine hydrochloride, and famotidine. On 06-MAR-2021, the patient experienced maternal exposure during pregnancy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of maternal exposure during pregnancy was not reported. The reporter provided no causality assessment. Company causality between covid-19 vaccine ad26.cov2.s, and maternal exposure during pregnancy was not related.  This report was non-serious.
None-given 1mL instead of 0.5mL at age 18. No adverse reaction reported.
Fatigue 12/8/2020 fever 100.3 degrees 12 noon 12/8/2020 shivers 12 noon 12/8/ 2020 and body aches
sore right eyelid; eyelid more swollen/right eyelid is much more swollen, red, and droopy; right eyelid is much more swollen, red, and droopy; right eyelid is much more swollen, red, and droopy; This is a spontaneous report received from a contactable consumer (patient herself). A 59-year-old female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL9265), via an unspecified route of administration on arm Left on 05Feb2021 15:15 at single dose for COVID-19 immunisation at workplace clinic. Medical history included Chronic reactivated Epstein Barr Virus and Cytomegalovirus. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that, the patient woke up Saturday on 06Feb2021 with sore right eyelid. Looked for evidence of stye but could not identify. Sunday, on 07Feb2021 eyelid more swollen, still no evidence of stye. Monday, on 08Feb2021, right eyelid was much more swollen, red, and droopy. Cannot locate a stye. Patient was treating with hot compresses. All the events were occurred on 06Feb2021 at 07:00 AM. The patient not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. The events were assessed as non-serious by the reporter. The outcome of the events was reported as not recovered.
. Patient received her first dose of Moderna COVID-19 on 4/10/21 at  Park. Vaccine given 0938. In the observation lot, the patient developed facial flushing. No dyspnea, hives, or itching. She was assessed by  PA-C. Vital signs were stable. She was given one dose of diphenhydamine 25 mg po. She was observed for a full 30 min without other events and was discharged.
9.5 x 9cm edematous area on left upper arm where Pneumovax and flu vaccine were given the night before. Pink ring around edematous area. Has had flu vaccine before without any adverse reaction per patient.
Myalgias, headache began morning after. Progressively worsened during the day and then developed lightheadedness, chills and fever (103.4F max).
post herpetic neuralgia; Herpes Zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unspecified age. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On an unknown date, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot # and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).   On an unknown date, after receiving zoster vaccine live (ZOSTAVAX), the patient suffered painful rash, nerve pain not accompanied by a rash and loss of sensation in her left breast. As a result of these symptoms patient presented to a medical provider and was diagnosed with herpes zoster and postherpetic neuralgia. Thereafter, patient has continued to suffer the effects of herpes zoster and postherpetic neuralgia. As a result, patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the product. As a result of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The events were considered related to zoster vaccine live (ZOSTAVAX).  Herpes zoster and post herpetic neuralgia were considered to be disabling.
Information has been received from a medical assistant concerning a 4 year old male patient who on an unknown date was vaccinated with varicella virus vaccine live.  It was noted that on 03/11/2004, the patient developed breakthrough varicella.  There was no product quality complaint reported.  No additional information was provided. Unspecified medical attention was sought.  Additional information has been requested.
Patient describes a Ramsay Hunt type reaction 1 week following initial COVID-19 vaccination with Moderna in April of 2021. Patient hospitalized 3 times for this.
First noticed itchy back. A few days later started to develop hive like reactions and welts along my back and torso. Red lines and wheels on torso, back, and arms consistent with dermatographia observed. 1.5 months have passed and still noticing hive like reactions on arms, legs, stomach, and back.
Area of redness and warm to touch x2 days. Redness measures 15 cm in length and 18 cm wide to LUE (site of vaccination). Penicillin prescribed.
PT IS VACCINATED BUT HAD ED VISIT ON 12.02.2021 FOR POSITIVE COVID
Pt was given MMRV vaccine instead of MMR; #2 of 2 MMR was due. No signs or symptoms of any problems - vaccines were tolerated well, and pt reported no issues later in the afternoon of 04/23/2021 and on 04/26/2021 when contacted by phone.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. Jonson and Johnson:04/06/21  Diagnosed covid positive:07/19/21 Sumptoms onset:07/16/21 Date of exposure:07/13/21 Exposure:work exposure Symptoms:Fatigue, muscle ache, runny nose, HA
HPV vaccine given 7/15/11 in office. Observed for 10 min in waiting room. Patient got lightheaded, gave granola bar, hadn't eaten yet. Presented on 7/18/11 to ER for suicidal ideation. Patient believes vaccine caused this. Has hx of depression/anxiety.
Nausea, vomiting, fever and inconsolable crying. MD ordered Phenergan suppositories 12.5mg 1/2 q 6 hours prn. Symptoms started the evening the injections were given. Pt was seen in urgent care setting on 10/25/00.
My arm/shoulder muscle hurt immediately from the tetanus (TD)shot. I expected the pain to go away like it always does after an injection. This pain has never gone away and just in the past couple weeks it has gotten to be a real problem. I have limited mobility in my left shoulder and when I go past the limits the pain is severe.  My arm will ache just sitting and watching tv.  It has gotten really difficult to get to sleep.
pt recvd vax; 1:30pm sudden severe crying, struggling respirations, gasping,circumoral pallor, BLE purple;1:40pm diaphoresis,pale,limp;whining,moaning;became dazed,non-responsive,although breathing;3:30pm at ofc, t 101.5;petechiae,took apap
Syncope, red-face, treated with cold compress and IV in ambulance. Stated after 2nd vaccine and last for approximately 5-10 minutes.
Pt reported no adverse events. What this report pertains to is to report pt given wrong dose of covid vaccine. Pt received 0.5 ml (full dose) moderna as her 3rd dose as immunocompromised, when she should have been given 0.25 ml (booster dose) moderna since the pt received JJ as 1st dose, and 0.5 ml additional dose of moderna for 2nd dose. Per pt, pt's physician also aware of the situation.
Patient had an allergic reaction. Onsite EMS was called vitals BP 130/76 HR 56 100% O2.  Patient was treated and released against medical advise.
This spontaneous report was received from a consumer refers to her friends who were each over 26 years old patients of unspecified demographics. On an unspecified dates the patients (drug administered to patient of inappropriate age) were vaccinated with GARDASIL (dose and lot numbers were unspecified), intramuscularly for an unknown indication. No adverse effects were reported. No product quality complaint (PQC) involved. Additional information has been requested.
Initial unsolicited report received from a nurse on 23 Sep 2016. This case involves 4-year-old male patient who was vaccinated with 0.5 ml dose of FLUZONE QIV (Batch number-UI658AA, expiration date and route were not reported) in arm on 21 Sep 2016. Medical history and concomitant medications were not reported. On 22 Sep 2016 evening, one day following the vaccination, the patient had rash under armpit same side as vaccine, fever and red swollen sore hot arm. Relevant laboratory data and corrective treatment were not reported. The outcome of the events was not reported. List of documents held by sender: none.
This spontaneous report as received from a pharmacist refers to a currently 55 year old male patient with high cholesterol. On 22-AUG-2012, the patient was vaccinated with a dose of ZOSTAVAX (Lot #, dose and route: Not provided). Concomitant therapies included pravastatin sodium and carisoprodol. The pharmacist reported that a patient developed shingles following vaccination with ZOSTAVAX (onset date: not provided). The pharmcist reported that the patient had a current case of shingles (start date of the current case of shingles was unspecified) and had at least one other prior case of shingles (date unspecified) since vaccination with ZOSTAVAX. The pharmacist was unsure if the patient had a history of shingles prior to vaccination with ZOSTAVAX. The patient was treated with valacyclovir hydrochloride. Patient's outcome was reported as not recovered. Additional information is not expected.
Sneezing, constant runny nose, achy bones/joints, sore throat, headache, fatigue, insomnia, discomfort/nausea; lasted 24 hours, with only a few lasting effects the next day but nothing severe. Tylenol/general antihistamines, rest, and hydration helped to relieve symptoms
Moderna covid vaccine given on 5/2/2023  was a 0.2ml dose with the wrong vial (pink top Bivalent) but should have been 0.25ml with blue top. This change was implemented  on 4/20/23 and we were unaware of the vial and dose change. Patient needs one more dose as she is currently now considered undervaccinated. I spoke with mom on 6/6/23 and she is aware of error and will come back for another dose in 1 month (received 1st correct dose on 6/6/23)
pt recvd vax & mom states by 230PM began to get fussy & cried until 4PM inconsolably; mom described the cry as unusual & high pitched; 4PM pt sent to sleep for 3 hrs; 10PM t100.5 ax-given APAP;